BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7218763)

  • 21. Reactions to dinitrochlorobenzene in patients with neuroblastoma and survival.
    Helson L
    J Natl Cancer Inst; 1976 Sep; 57(3):723-4. PubMed ID: 978776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cellular immunity in leprosy patients].
    de Arruda MS; de Arruda OS; Fleury RN; Garcia Dde O; Opromolla DV; Ura S
    Med Cutan Ibero Lat Am; 1982; 10(4):231-8. PubMed ID: 6763656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cell mediated immunity in healthy contacts of leprosy.
    Kurhade AM; Akulwar SL; Pathak AA; Thakar YS; Dhanvijay AG
    Indian J Pathol Microbiol; 1996 Jul; 39(3):197-201. PubMed ID: 8972148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes].
    Bianucci P; Pastorino G; Brondi P
    Minerva Med; 1982 Oct; 73(41):2891-5. PubMed ID: 7133502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dinitrochlorobenzene contact sensitization in patients with end-stage renal disease.
    Waltzer WC; Gonder MJ
    Allergol Immunopathol (Madr); 1984; 12(6):479-82. PubMed ID: 6335629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flare-up of DNCB test induced by lepra reaction.
    Garcia-Perez A
    Contact Dermatitis; 1982 May; 8(3):205. PubMed ID: 7094576
    [No Abstract]   [Full Text] [Related]  

  • 27. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
    Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
    Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
    [No Abstract]   [Full Text] [Related]  

  • 28. [Importance of the correlation of the DNCB and T lymphocyte test in the evaluation of cellular immunity in various forms of glomerulonephritis].
    Redzepagić B; Tomasević M; Zildzić V
    Med Pregl; 1983; 36(9-10):401-4. PubMed ID: 6609301
    [No Abstract]   [Full Text] [Related]  

  • 29. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
    Lipenský R; Urban K
    Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidermal reactivity of DNP (dinitrophenyl) compounds following epidermal DNCB (2,4-dinitrochlorobenzene) sensitization].
    Lübbe D; Schwartze G; Wozniak KD
    Dermatol Monatsschr; 1984; 170(6):395-403. PubMed ID: 6468710
    [No Abstract]   [Full Text] [Related]  

  • 32. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of cell mediated immunity in malnourished children using DNCB skin sensitization test.
    Sanjeev Rai B; Krishnamurthy PN; Rao BR
    Indian Pediatr; 1981 Jan; 18(1):29-33. PubMed ID: 7262994
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preliminary remarks on the D.N.C.B. sensitization in leprosy patients].
    Charles-Sainte-Claire R; Cales-Quist D; Helenon R
    Acta Leprol; 1979; (76-77):201-6. PubMed ID: 121835
    [No Abstract]   [Full Text] [Related]  

  • 35. Patch testing, tuberculin testing and sensitization with dinitrochlorobenzene and nitrosodimethylanilini of patients with atopic dermatitis.
    Forsbeck M; Hovmark A; Skog E
    Acta Derm Venereol; 1976; 56(2):135-8. PubMed ID: 58522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of clinical, histological and immunological features across the leprosy spectrum.
    Narayan NP; Ramu G; Desikan KV; Vallishayee RS
    Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of cell mediated immunity in leprosy: changing trends in the immunological spectrum of the disease.
    Saha K; Mittal MM
    Clin Exp Immunol; 1971 Jun; 8(6):901-9. PubMed ID: 5091616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immunity in Hurler's syndrome.
    Mendes E; Toledo SP
    Allergol Immunopathol (Madr); 1975; 3(2):95-8. PubMed ID: 808113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the immune status in vivo by the 2,4-dinitro-1-chlorobenzene contact allergy time (DNCB-CAT).
    Przybilla B; Burg G; Thieme C
    Dermatologica; 1983; 167(1):1-5. PubMed ID: 6628792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative DNCB reaction in patients with hypernephroma].
    Kreutz G; Bandhauer K
    Z Urol Nephrol; 1980 Feb; 73(2):73-8. PubMed ID: 7445781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.